Skip to main content

Advertisement

Log in

2-(Chloromethyl)-3-phenylquinazolin-4(3H)-ones as potent anticancer agents; cytotoxicity, molecular docking and in silico studies

  • Original Paper
  • Published:
Journal of the Iranian Chemical Society Aims and scope Submit manuscript

Abstract

In order to show antiproliferation and cancerous cell growth inhibition of quinazoline derivatives, a series of 2-(chloromethyl)-3-phenylquinazolin-4(3H)-ones (H1H11) were synthesized. In vitro cytotoxic activities were evaluated against three human cancer cell lines: A549, MCF-7 and SW1116 using colorimetric MTT assay. Comparing their effects together and with cisplatin as a positive control indicated that H3, H5 and H6 exhibited better antitumor activities on A549 cell line with IC50 values less than 10 μM versus 12 μM for cisplatin. In the case of MCF-7 and SW1116 cell lines, almost all compounds displayed better cytotoxic activities than cisplatin. Molecular docking studies were applied on epidermal growth factor receptor (EGFR) as the main target of quinazoline scaffolds in cancer therapy to predict the binding energies, binding modes and orientation of these ligands toward the active site of the receptor. In silico physicochemical parameters and ADMET profiling calculations also were done. All compounds showed lower binding energies than erlotinib, the inhibitor of EGFR. Taken together, our findings showed potential anticancer effect of quinazoline compounds bearing various phenyl ring substitutions.

Graphic abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Scheme 1
Scheme 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. M. Saeedi, M. Mohammadi-Khanaposhtani, P. Pourrabia, N. Razzaghi, R. Ghadimi, S. Imanparast, Bioorg. Chem. 83, 161 (2019)

    Article  CAS  Google Scholar 

  2. S. Ravez, O. Castillo-Aguilera, P. Depreux, L. Goossens, Expert Opin. Ther. Pat. 25, 789 (2015)

    Article  CAS  Google Scholar 

  3. P.C. Sharma, G. Kaur, R. Pahwa, A. Sharma, H. Rajak, Curr. Med. Chem. 18, 4786 (2011)

    Article  CAS  Google Scholar 

  4. K. Rakesh, H. Manukumar, D.C. Gowda, Bioorg. Med. Chem. Lett 25, 1072 (2015)

    Article  CAS  Google Scholar 

  5. S. Gatadi, T.V. Lakshmi, S. Nanduri, Eur. J. Med. Chem. 170, 157 (2019)

    Article  CAS  Google Scholar 

  6. J. Bartroli, E. Turmo, M. Algueró, E. Boncompte, M.L. Vericat, L. Conte, J. Med. Chem. 41, 1869 (1998)

    Article  CAS  Google Scholar 

  7. Z. Wang, M. Wang, X. Yao, Y. Li, J. Tan, L. Wang, Eur. J. Med. Chem. 53, 275 (2012)

    Article  CAS  Google Scholar 

  8. A. Hameed, M. Al-Rashida, M. Uroos, S.A. Ali, A.M. Ishtiaq, Expert Opin. Ther. Pat. 28, 281 (2018)

    Article  CAS  Google Scholar 

  9. Y. Le, Y. Gan, Y. Fu, J. Liu, W. Li, X. Zou, J. Enzyme. Inhib. Med. 35, 555 (2020)

    Article  CAS  Google Scholar 

  10. A.-M. Alaa, L.A. Abou-Zeid, K.E.H. ElTahir, R.R. Ayyad, A.-A. Magda, A.S. El-Azab, Euro. J. Med. Chem. 121, 410 (2016)

    Article  Google Scholar 

  11. J. Fricker, Lancet. Oncol. 7, 621 (2006)

    Article  Google Scholar 

  12. S. Garofalo, R. Rosa, R. Bianco, G, , Tortora. Expert Opin. Ther. Pat. 18, 889 (2008)

    Article  CAS  Google Scholar 

  13. G. Marzaro, A. Guiotto, A. Chilin, Expert Opin. Ther. Pat. 22, 223 (2012)

    Article  CAS  Google Scholar 

  14. M.N. Noolvi, H.M. Patel, V. Bhardwaj, A. Chauhan, Euro. J. Med. Chem. 46, 2327 (2011)

    Article  CAS  Google Scholar 

  15. W. Dohle, F.L. Jourdan, G. Menchon, A.E. Prota, P.A. Foster, P. Mannion, J. Med. Chem. 61, 1031 (2018)

    Article  CAS  Google Scholar 

  16. S. El-Sayed, K. Metwally, A.A. El-Shanawani, L.M. Abdel-Aziz, H. Pratsinis, D. Kletsas, Chem. Cent. J. 11, 1 (2017)

    Article  Google Scholar 

  17. F.L. Faraj, M. Zahedifard, M. Paydar, C.Y. Looi, N. Abdul Majid, H.M. Ali, Sci. World J. 2014, 1 (2014)

  18. N. Rahmannejadi, S. Khabnadideh, I. Yavari, Monatsh. Chem. 149, 2085 (2018)

    Article  CAS  Google Scholar 

  19. N. Rahmannejadi, I. Yavari, S. Khabnadideh, J. Heterocycl. Chem. 57, 978 (2020)

    Article  CAS  Google Scholar 

  20. N. Rahmannejadi, K. Zomorodian, Z. Faghih, Z. Faghih, S. Khabnadideh, J. Pharm. Res. Int. 20, 1 (2017)

  21. Z. Faghih, N. Rahmannejadi, R. Sabet, K. Zomorodian, M. Asad, S. Khabnadideh, Res. Pharm. Sci. 14, 115 (2019)

    Article  Google Scholar 

  22. P. Ramesh, D. Srinivasulu, D. Subbarao, K. Hemakumar, D. Rajasekhar, C. Nagaraju, Der Pharm. Lett. 4, 1344 (2012)

    CAS  Google Scholar 

  23. H. Patel, A. Shirkhedkar, S. Bari, K. Patil, A. Arambhi, C. Pardeshi, Bull. Fac. Pharm. 56, 83 (2018)

    Google Scholar 

  24. P. Selvam, N. Murugesh, M. Chandramohan, C. Pannecouque, E.D. Clercq, Indian J. Pharm. Sci. 72, 806 (2010)

    Article  CAS  Google Scholar 

  25. H.-Z. Li, H.-Y. He, Y.-Y. Han, X. Gu, L. He, Q.-R. Qi, Molecules 15, 9473 (2010)

    Article  CAS  Google Scholar 

  26. Z. Faghih, A. Neshat, P. Mastrorilli, V. Gallo, Z. Faghih, S. Gilanchi, Inorg. Chim. Acta. 512, 119896 (2020)

    Article  CAS  Google Scholar 

  27. M. Fereidoonnezhad, H.R. Shahsavari, S. Abedanzadeh, A. Nezafati, A. Khazali, P. Mastrorilli, M. Babaghasabha, J. Webb, Z. Faghih, Z. Faghih, S. Bahemmat, M. Hassan Beyzavi, New J. Chem. 42, 8681 (2018)

    Article  CAS  Google Scholar 

  28. W. Humphrey, A. Dalke, K. Schulten, J. Mol. Graph. 14, 33 (1996)

    Article  CAS  Google Scholar 

  29. M. Fereidoonnezhad, S.M.H. Tabaei, A. Sakhteman, H. Seradj, Z. Faghih, Z. Faghih, J. Mol. Struct. 1221, 128689 (2020)

    Article  CAS  Google Scholar 

  30. M. Fereidoonnezhad, Z. Faghih, A. Mojaddami, Z. Rezaei, A. Sakhteman, Int. J. Pharm. Res. 16, 981 (2017)

    CAS  Google Scholar 

  31. R. Sabet, S. Khabnadideh, D. Fathi, L. Emami, J. Pharm. Res. Int. 22, 1 (2019)

    Article  Google Scholar 

  32. L. Emami, L. Zamani, R. Sabet, K. Zomorodian, Z. Rezaei, Z. Faghih, Trends Pharmacol. Sci. 6, 113 (2020)

    CAS  Google Scholar 

  33. R.S. Giri, H.M. Thaker, T. Giordano, J. Williams, D. Rogers, K.K. Vasu, Bioorg. Med. Chem. 18, 2796 (2010)

    Article  CAS  Google Scholar 

  34. K. Metwally, H. Pratsinis, D. Kletsas, Eur. J. Med. Chem. 133, 340 (2017)

    Article  CAS  Google Scholar 

  35. W. Huang, R. Huang, M.S. Attene-Ramos, S. Sakamuru, E.E. Englund, J. Inglese, Bioorg. Med Chem. Lett. 21, 5239 (2011)

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Financial support from the Shiraz University of Medical Sciences with Grant numbers of 98-01-36-21224 and 99-01-16-23354 is gratefully acknowledged.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Zeinab Faghih or Zahra Faghih.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 1811 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Emami, L., Faghih, Z., Khabnadideh, S. et al. 2-(Chloromethyl)-3-phenylquinazolin-4(3H)-ones as potent anticancer agents; cytotoxicity, molecular docking and in silico studies. J IRAN CHEM SOC 18, 1877–1889 (2021). https://doi.org/10.1007/s13738-021-02168-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13738-021-02168-1

Keywords

Navigation